$ASDS.OB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Dougherty's Pharmacy, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Dougherty's Pharmacy, Inc.. Get notifications about new insider transactions in Dougherty's Pharmacy, Inc. for free.
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | P | 0.20 | 60,000 | 12,000 | 60,950 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 40,950 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 45,950 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Buy | M | 0.00 | 5,000 | 0 | 373,423 | 368.4 K to 373.4 K (+1.36 %) |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Buy | M | 0.00 | 5,000 | 0 | 368,423 | 363.4 K to 368.4 K (+1.38 %) |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | P | 0.20 | 60,000 | 12,000 | 90,500 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 30,500 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 35,500 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Buy | M | 0.00 | 5,000 | 0 | 72,681 | 67.7 K to 72.7 K (+7.39 %) |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Buy | M | 0.00 | 5,000 | 0 | 67,681 | 62.7 K to 67.7 K (+7.98 %) |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Option Exercise | P | 0.20 | 60,000 | 12,000 | 70,000 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Option Exercise | M | 0.00 | 5,000 | 0 | 10,000 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | M | 0.00 | 5,000 | 0 | 4,003,493 | 4 M to 4 M (+0.13 %) |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Option Exercise | P | 0.20 | 60,000 | 12,000 | 75,150 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Option Exercise | M | 0.00 | 5,000 | 0 | 15,150 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Option Exercise | M | 0.00 | 5,000 | 0 | 20,150 | |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Buy | M | 0.00 | 5,000 | 0 | 176,453 | 171.5 K to 176.5 K (+2.92 %) |
May 03 2019 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Buy | M | 0.00 | 5,000 | 0 | 171,453 | 166.5 K to 171.5 K (+3.00 %) |
Apr 22 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.17 | 100,000 | 17,250 | 3,998,493 | 3.9 M to 4 M (+2.57 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.11 | 15,468 | 1,686 | 3,898,493 | 3.9 M to 3.9 M (+0.40 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.10 | 30,000 | 3,000 | 3,883,025 | 3.9 M to 3.9 M (+0.78 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.11 | 10,000 | 1,100 | 3,853,025 | 3.8 M to 3.9 M (+0.26 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.11 | 10,000 | 1,100 | 3,843,025 | 3.8 M to 3.8 M (+0.26 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.10 | 23,282 | 2,212 | 3,833,025 | 3.8 M to 3.8 M (+0.61 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.11 | 4,725 | 543 | 3,809,743 | 3.8 M to 3.8 M (+0.12 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.11 | 5,275 | 606 | 3,805,018 | 3.8 M to 3.8 M (+0.14 %) |
Apr 11 2019 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | P | 0.09 | 20,000 | 1,800 | 3,799,743 | 3.8 M to 3.8 M (+0.53 %) |
Jul 31 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | M | 0.00 | 5,250 | 0 | 40,500 | |
Jul 31 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Buy | M | 0.00 | 5,250 | 0 | 363,423 | 358.2 K to 363.4 K (+1.47 %) |
Jul 31 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Option Exercise | M | 0.00 | 5,250 | 0 | 40,500 | |
Jul 31 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Buy | M | 0.00 | 5,250 | 0 | 1,673,703 | 1.7 M to 1.7 M (+0.31 %) |
Jul 31 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | M | 0.00 | 5,250 | 0 | 40,500 | |
Jul 31 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Buy | M | 0.00 | 5,250 | 0 | 62,681 | 57.4 K to 62.7 K (+9.14 %) |
May 25 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | M | 0.00 | 5,200 | 0 | 25,150 | |
May 25 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Buy | M | 0.00 | 5,200 | 0 | 358,173 | 353 K to 358.2 K (+1.47 %) |
May 25 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Option Exercise | M | 0.00 | 5,200 | 0 | 25,150 | |
May 25 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | CEO, Interim Pres., ... | Buy | M | 0.00 | 5,200 | 0 | 1,668,453 | 1.7 M to 1.7 M (+0.31 %) |
May 25 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | M | 0.00 | 5,200 | 0 | 25,150 | |
May 25 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Buy | M | 0.00 | 5,200 | 0 | 57,431 | 52.2 K to 57.4 K (+9.96 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Option Exercise | M | 0.00 | 20,000 | 0 | 20,000 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | Phillips Troy | Director | Buy | J | 0.00 | 74,113 | 0 | 3,779,743 | 3.7 M to 3.8 M (+2.00 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | J | 0.00 | 600 | 0 | 50,950 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | M | 0.00 | 20,000 | 0 | 50,350 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | M | 0.00 | 5,100 | 0 | 30,350 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Buy | J | 0.00 | 6,821 | 0 | 352,972 | 346.2 K to 353 K (+1.97 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Buy | M | 0.00 | 5,100 | 0 | 346,151 | 341.1 K to 346.2 K (+1.50 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Option Exercise | J | 0.00 | 600 | 0 | 50,950 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Option Exercise | M | 0.00 | 20,000 | 0 | 50,350 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Option Exercise | M | 0.00 | 5,100 | 0 | 30,350 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Buy | J | 0.00 | 3,099 | 0 | 1,666,253 | 1.7 M to 1.7 M (+0.19 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Buy | J | 0.00 | 32,513 | 0 | 1,666,253 | 1.6 M to 1.7 M (+1.99 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Buy | M | 0.00 | 5,100 | 0 | 1,630,740 | 1.6 M to 1.6 M (+0.31 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | Heil Mark S | President and CFO | Option Exercise | J | 0.00 | 8,238 | 0 | 425,428 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | Heil Mark S | President and CFO | Option Exercise | M | 0.00 | 98,532 | 0 | 417,190 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | Heil Mark S | President and CFO | Buy | J | 0.00 | 3,909 | 0 | 297,882 | 294 K to 297.9 K (+1.33 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | Heil Mark S | President and CFO | Buy | M | 0.00 | 98,532 | 0 | 293,973 | 195.4 K to 294 K (+50.42 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | J | 0.00 | 600 | 0 | 50,950 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | M | 0.00 | 20,000 | 0 | 50,350 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | M | 0.00 | 5,100 | 0 | 30,350 | |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Buy | J | 0.00 | 926 | 0 | 52,231 | 51.3 K to 52.2 K (+1.80 %) |
Jan 08 2018 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Buy | M | 0.00 | 5,100 | 0 | 51,305 | 46.2 K to 51.3 K (+11.04 %) |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Option Exercise | M | 0.00 | 5,150 | 0 | 35,350 | |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | CURETON WILL | Director | Buy | M | 0.00 | 5,150 | 0 | 46,205 | 41.1 K to 46.2 K (+12.54 %) |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | Heil Mark S | President and CFO | Option Exercise | M | 0.00 | 10,300 | 0 | 513,700 | |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | Heil Mark S | President and CFO | Buy | M | 0.00 | 10,300 | 0 | 195,441 | 185.1 K to 195.4 K (+5.56 %) |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Option Exercise | M | 0.00 | 5,150 | 0 | 35,350 | |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | LEVECCHIO ANTHONY J | Director | Buy | M | 0.00 | 5,150 | 0 | 341,051 | 335.9 K to 341.1 K (+1.53 %) |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Option Exercise | M | 0.00 | 5,150 | 0 | 35,350 | |
Nov 13 2017 | ASDS.OB | Dougherty's Pharma ... | LESLIE JAMES | Director | Buy | M | 0.00 | 5,150 | 0 | 1,625,640 | 1.6 M to 1.6 M (+0.32 %) |
Jan 03 2008 | ASDS.OB | ASCENDANT SOLUTION ... | NONOMAQUE CURT | Director | Grant | A | 0.64 | 7,813 | 5,000 | 78,584 | 70.8 K to 78.6 K (+11.04 %) |
Jan 03 2008 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.64 | 13,672 | 8,750 | 286,175 | 272.5 K to 286.2 K (+5.02 %) |
Jan 03 2008 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.64 | 7,813 | 5,000 | 96,649 | 88.8 K to 96.6 K (+8.79 %) |
Oct 02 2007 | ASDS.OB | ASCENDANT SOLUTION ... | NONOMAQUE CURT | Director | Grant | A | 0.60 | 8,334 | 5,000 | 70,771 | 62.4 K to 70.8 K (+13.35 %) |
Oct 02 2007 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.60 | 14,584 | 8,750 | 272,503 | 257.9 K to 272.5 K (+5.65 %) |
Oct 02 2007 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.60 | 8,334 | 5,000 | 88,836 | 80.5 K to 88.8 K (+10.35 %) |
Jul 11 2007 | ASDS.OB | ASCENDANT SOLUTION ... | Heil Mark S | VP Finance and CFO | Grant | A | 0.65 | 100,000 | 65,000 | 100,000 | 0 to 100 K |
Jul 02 2007 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.64 | 7,813 | 5,000 | 80,502 | 72.7 K to 80.5 K (+10.75 %) |
Jul 02 2007 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.64 | 13,672 | 8,750 | 257,919 | 244.2 K to 257.9 K (+5.60 %) |
Jul 02 2007 | ASDS.OB | ASCENDANT SOLUTION ... | NONOMAQUE CURT | Director | Grant | A | 0.64 | 7,813 | 5,000 | 62,437 | 54.6 K to 62.4 K (+14.30 %) |
Jun 04 2007 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.70 | 7,500 | 5,250 | 72,689 | 65.2 K to 72.7 K (+11.51 %) |
Jun 04 2007 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.70 | 7,500 | 5,250 | 244,247 | 236.7 K to 244.2 K (+3.17 %) |
Jun 04 2007 | ASDS.OB | ASCENDANT SOLUTION ... | NONOMAQUE CURT | Director | Grant | A | 0.70 | 7,500 | 5,250 | 54,624 | 47.1 K to 54.6 K (+15.92 %) |
Apr 06 2007 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.37 | 13,513 | 5,000 | 65,189 | 51.7 K to 65.2 K (+26.15 %) |
Apr 06 2007 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.37 | 23,648 | 8,750 | 236,747 | 213.1 K to 236.7 K (+11.10 %) |
Apr 06 2007 | ASDS.OB | ASCENDANT SOLUTION ... | NONOMAQUE CURT | Director | Grant | A | 0.37 | 13,513 | 5,000 | 47,124 | 33.6 K to 47.1 K (+40.20 %) |
Jan 09 2007 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.45 | 11,111 | 5,000 | 51,676 | 40.6 K to 51.7 K (+27.39 %) |
Jan 09 2007 | ASDS.OB | ASCENDANT SOLUTION ... | NONOMAQUE CURT | Director | Grant | A | 0.45 | 11,111 | 5,000 | 33,611 | 22.5 K to 33.6 K (+49.38 %) |
Jan 09 2007 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.45 | 19,444 | 8,750 | 213,099 | 193.7 K to 213.1 K (+10.04 %) |
Nov 07 2006 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.40 | 12,500 | 5,000 | 40,565 | 28.1 K to 40.6 K (+44.54 %) |
Nov 07 2006 | ASDS.OB | ASCENDANT SOLUTION ... | NONOMAQUE CURT | Director | Grant | A | 0.40 | 12,500 | 5,000 | 22,500 | 10 K to 22.5 K (+125.00 %) |
Nov 07 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.40 | 21,875 | 8,750 | 193,655 | 171.8 K to 193.7 K (+12.73 %) |
Jul 28 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.50 | 7,500 | 3,750 | 171,780 | 164.3 K to 171.8 K (+4.57 %) |
Jul 05 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.62 | 14,113 | 8,750 | 164,280 | 150.2 K to 164.3 K (+9.40 %) |
Jul 05 2006 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 0.62 | 8,065 | 5,000 | 28,065 | 20 K to 28.1 K (+40.33 %) |
May 25 2006 | ASDS.OB | ASCENDANT SOLUTION ... | BOYD GARY W | Vice President-Fina ... | Grant | A | 0.75 | 10,000 | 7,500 | 69,000 | 59 K to 69 K (+16.95 %) |
Apr 20 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.65 | 1,346 | 875 | 150,167 | 148.8 K to 150.2 K (+0.90 %) |
Apr 20 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.65 | 13,462 | 8,750 | 148,821 | 135.4 K to 148.8 K (+9.95 %) |
Mar 16 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LESLIE JAMES | Chairman | Option Exercise | M | 0.24 | 200,000 | 48,000 | 0 | |
Mar 16 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LESLIE JAMES | Chairman | Buy | M | 0.24 | 200,000 | 48,000 | 4,391,300 | 4.2 M to 4.4 M (+4.77 %) |
Feb 15 2006 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 0.55 | 15,909 | 8,750 | 135,359 | 119.5 K to 135.4 K (+13.32 %) |
Dec 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | BOWE DAVID E | President & CEO | Option Exercise | M | 0.24 | 100,000 | 24,000 | 450,000 | |
Dec 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | BOWE DAVID E | President & CEO | Buy | M | 0.24 | 100,000 | 24,000 | 685,000 | 585 K to 685 K (+17.09 %) |
Sep 12 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LESLIE JAMES | Chairman | Option Exercise | M | 0.24 | 100,000 | 24,000 | 200,000 | |
Sep 12 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LESLIE JAMES | Chairman | Buy | M | 0.24 | 100,000 | 24,000 | 4,191,300 | 4.1 M to 4.2 M (+2.44 %) |
Sep 12 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LESLIE JAMES | Chairman | Gift | G | 0.00 | 15,000 | 0 | 4,091,300 | 4.1 M to 4.1 M (-0.37 %) |
Aug 30 2005 | ASDS.OB | ASCENDANT SOLUTION ... | BOYD GARY W | Vice President-Fina ... | Buy | P | 0.75 | 4,000 | 3,000 | 59,000 | 55 K to 59 K (+7.27 %) |
Aug 30 2005 | ASDS.OB | ASCENDANT SOLUTION ... | BOYD GARY W | Vice President-Fina ... | Buy | P | 0.80 | 5,000 | 4,000 | 55,000 | 50 K to 55 K (+10.00 %) |
Aug 30 2005 | ASDS.OB | ASCENDANT SOLUTION ... | BOWE DAVID E | President & CEO | Buy | P | 0.75 | 5,000 | 3,750 | 1,175,250 | 1.2 M to 1.2 M (+0.43 %) |
Aug 30 2005 | ASDS.OB | ASCENDANT SOLUTION ... | BOWE DAVID E | President & CEO | Buy | P | 0.75 | 5,000 | 3,750 | 1,170,250 | 1.2 M to 1.2 M (+0.43 %) |
Jun 13 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | P | 1.50 | 10,000 | 15,000 | 119,450 | 109.5 K to 119.5 K (+9.14 %) |
May 31 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | P | 1.49 | 1,950 | 2,906 | 109,450 | 107.5 K to 109.5 K (+1.81 %) |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 1.45 | 2,500 | 3,625 | 20,000 | 17.5 K to 20 K (+14.29 %) |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 1.45 | 7,500 | 10,875 | 17,500 | 10 K to 17.5 K (+75.00 %) |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Grant | A | 1.45 | 10,000 | 14,500 | 10,000 | 0 to 10 K |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | CURETON WILL | Director | Sell | J | 1.01 | 76,000 | 76,760 | 0 | 76 K to 0 (-100.00 %) |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | BLOCH JONATH R | Director | Grant | A | 1.45 | 2,500 | 3,625 | 2,500 | 0 to 2.5 K |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | P | 1.50 | 21,252 | 31,878 | 107,500 | 86.2 K to 107.5 K (+24.64 %) |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | P | 1.47 | 3,748 | 5,510 | 86,248 | 82.5 K to 86.2 K (+4.54 %) |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 1.45 | 7,500 | 10,875 | 82,500 | 75 K to 82.5 K (+10.00 %) |
May 20 2005 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Grant | A | 1.45 | 17,500 | 25,375 | 75,000 | 57.5 K to 75 K (+30.43 %) |
Nov 24 2004 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | P | 1.10 | 7,500 | 8,250 | 57,500 | 50 K to 57.5 K (+15.00 %) |
Nov 24 2004 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | L | 1.10 | 6,000 | 6,600 | 50,000 | 44 K to 50 K (+13.64 %) |
Nov 22 2004 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | P | 1.10 | 2,500 | 2,740 | 44,000 | 41.5 K to 44 K (+6.02 %) |
Nov 22 2004 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | P | 1.06 | 8,000 | 8,465 | 41,500 | 33.5 K to 41.5 K (+23.88 %) |
Nov 22 2004 | ASDS.OB | ASCENDANT SOLUTION ... | LEVECCHIO ANTHONY J | Director | Buy | L | 0.99 | 6,000 | 5,910 | 33,500 | 27.5 K to 33.5 K (+21.82 %) |
Jun 21 2004 | ASDS.OB | ASCENDANT SOLUTION ... | BLOCH RICHARD | Director | Option Exercise | M | 0.24 | 50,000 | 12,000 | 25,000 | |
Jun 21 2004 | ASDS.OB | ASCENDANT SOLUTION ... | BLOCH RICHARD | Director | Buy | M | 0.24 | 50,000 | 12,000 | 50,000 | 0 to 50 K |
Jun 02 2004 | ASDS.OB | ASCENDANT SOLUTION ... | LESLIE JAMES | Director | Option Exercise | M | 0.24 | 100,000 | 24,000 | 300,000 | |
Jun 02 2004 | ASDS.OB | ASCENDANT SOLUTION ... | LESLIE JAMES | Director | Buy | M | 0.24 | 100,000 | 24,000 | 4,106,300 | 4 M to 4.1 M (+2.50 %) |
Jun 02 2004 | ASDS.OB | ASCENDANT SOLUTION ... | BOWE DAVID E | President, CEO, CFO | Option Exercise | M | 0.24 | 50,000 | 12,000 | 550,000 | |
Jun 02 2004 | ASDS.OB | ASCENDANT SOLUTION ... | BOWE DAVID E | President, CEO, CFO | Buy | M | 0.24 | 50,000 | 12,000 | 580,000 | 530 K to 580 K (+9.43 %) |
Page: 1